1. Home
  2. TNGX vs CVLT Comparison

TNGX vs CVLT Comparison

Compare TNGX & CVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

N/A

Current Price

$27.08

Market Cap

4.5B

Sector

Health Care

ML Signal

N/A

Logo Commvault Systems Inc.

CVLT

Commvault Systems Inc.

N/A

Current Price

$150.06

Market Cap

5.4B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
TNGX
CVLT
Founded
2014
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
5.4B
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
TNGX
CVLT
Price
$27.08
$150.06
Analyst Decision
Strong Buy
Buy
Analyst Count
10
18
Target Price
$21.78
$139.53
AVG Volume (30 Days)
2.7M
594.6K
Earning Date
05-08-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
26.89
N/A
EPS
N/A
1.58
Revenue
$62,384,000.00
$1,183,690,000.00
Revenue This Year
N/A
$13.29
Revenue Next Year
N/A
$13.20
P/E Ratio
N/A
$90.07
Revenue Growth
48.29
18.89
52 Week Low
$5.60
$71.75
52 Week High
$34.39
$200.68

Technical Indicators

Market Signals
Indicator
TNGX
CVLT
Relative Strength Index (RSI) 44.84 61.78
Support Level $19.74 $117.56
Resistance Level $28.41 $154.83
Average True Range (ATR) 1.76 5.82
MACD -0.50 -1.59
Stochastic Oscillator 10.98 69.79

Price Performance

Historical Comparison
TNGX
CVLT

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

About CVLT Commvault Systems Inc.

CommVault Systems Inc provides cyber resiliency solutions designed to help the enterprise protect, secure, and recover its data, applications, and identity systems in a world of increasing cyber threats and attacks. Its offerings provide cyber resilience, including data protection, cyber recovery, data security, and governance, aiming to enable customers to continue business. The company delivers its solutions through Commvault Cloud, a cloud native platform that unifies data security, cyber recovery and identity resilience across on-premises, hybrid, multi-cloud, and software-as-a-service environments. It sells its offerings through subscription-based arrangements, including SaaS and term-based subscriptions, and also offers perpetual licenses, customer support, and professional services.

Share on Social Networks: